# Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors

> **NCT06190275** · NA · RECRUITING · sponsor: **Grit Biotechnology** · enrollment: 32 (estimated)

## Conditions studied

- HNSCC

## Interventions

- **BIOLOGICAL:** GT201 in combination with PD-1 inhibitors

## Key facts

- **NCT ID:** NCT06190275
- **Lead sponsor:** Grit Biotechnology
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-12
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-04-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06190275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06190275, "Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06190275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*